MindBio Therapeutics Corp.
MBIO
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.89M | -2.55M | -1.79M | -1.04M | -398.70K |
| Total Depreciation and Amortization | -56.80K | 1.00K | 1.00K | 57.80K | 57.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.98M | 1.92M | 1.08M | 789.50K | 212.70K |
| Change in Net Operating Assets | 265.90K | 341.50K | 387.50K | -7.00K | 61.00K |
| Cash from Operations | -703.80K | -293.40K | -319.70K | -199.80K | -67.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 6.40K | 6.40K | 6.40K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 6.40K | 6.40K | 6.40K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30K | -1.30K | -9.30K | -20.60K | -20.60K |
| Issuance of Common Stock | 1.44M | 440.40K | 440.40K | 165.00K | 165.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00 | -400.00 | -400.00 | 0.00 | 0.00 |
| Cash from Financing | 938.80K | 282.90K | 277.50K | 93.80K | 93.80K |
| Foreign Exchange rate Adjustments | -13.60K | -13.60K | -13.60K | -45.60K | -45.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 227.70K | -17.70K | -49.30K | -151.50K | -19.00K |